Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for PeopleBio Co., Ltd. (304840:KRX), powered by AI.
PeopleBio Co., Ltd. is currently trading at ₩978. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for PeopleBio Co., Ltd. on Alpha Lenz.
PeopleBio Co., Ltd.'s P/E ratio is -1.9.
“PeopleBio Co., Ltd. trades at a P/E of -1.9 (undervalued) with modest ROE of -79.2%. 3Y revenue CAGR of 86.3% highlights clear growth momentum.”
Ask for details →PeopleBio Co., Ltd. is a biotechnology company primarily engaged in research and development within the medical diagnostics industry. The company focuses on developing advanced diagnostic technologies, particularly in the fields of neurodegenerative diseases and cancer detection. PeopleBio is renowned for its innovative methods in protein misfolding cyclic amplification and multiplex detection systems, which are designed to improve early diagnosis of critical diseases like Alzheimer's. By emphasizing early detection, PeopleBio contributes significantly to improving patient outcomes and potentially reducing the long-term costs of healthcare. The company's products are crucial for healthcare providers, laboratories, and research institutions across various regions, facilitating more accurate and faster diagnoses. Operating in a rapidly evolving biotechnological landscape, PeopleBio plays a critical role in advancing medical diagnostics and bringing enhanced precision and reliability to clinical testing services globally.
“PeopleBio Co., Ltd. trades at a P/E of -1.9 (undervalued) with modest ROE of -79.2%. 3Y revenue CAGR of 86.3% highlights clear growth momentum.”
Ask for details →PeopleBio Co., Ltd. (ticker: 304840) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $20.8B.
The current price is ₩978 with a P/E ratio of -1.95x and P/B of 2.53x.
ROE is -79.18% and operating margin is -308.22%. Annual revenue is $3.7B.